phrykt

Johnson & Johnson (JNJ) revenue: $94.2B

Johnson & Johnson reported $94.2B of revenue for the year ended Dec 28, 2025, up 6.0% from $88.8B a year earlier.

From Johnson & Johnson's filings with the SEC · Read the filing · JNJ stock page

Johnson & Johnson revenue by year

$78.7B2021$80B2022$85.2B2023$88.8B2024$94.2B2025

#42 of 3,622 US companies by revenue · See the full ranking

Year endedRevenueChange
Dec 28, 2025$94.2B+6%
Dec 29, 2024$88.8B+4%
Dec 31, 2023$85.2B+6%
Jan 1, 2023$80B+2%
Jan 2, 2022$78.7B–

Revenue of similar companies

Companies in the same industry as Johnson & Johnson, by SEC industry code, with the closest revenue. Each name opens the same page for that company.

CompanyRevenue, latest yearYear ended
Johnson & Johnson$94.2BDec 28, 2025
Eli Lilly$65.2BDec 31, 2025
Merck$65BDec 31, 2025
Pfizer$62.6BDec 31, 2025
AbbVie$61.2BDec 31, 2025
Bristol Myers Squibb$48.2BDec 31, 2025
Abbott Laboratories$44.3BDec 31, 2025

Questions and answers

What is Johnson & Johnson's revenue?

Johnson & Johnson reported $94.2B of revenue for the year ended Dec 28, 2025, up 6.0% from $88.8B a year earlier.

Numbers as reported in Johnson & Johnson's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology